Sequencing Haiti’s Cholera Epidemic
According to the most detailed genetic analysis yet of the strain of cholera bacteria infecting people in Haiti, the pathogen most likely originated in South Asia rather than the Caribbean or Latin America. While scientists still don’t know exactly how the bacteria made its way to Haiti, the findings suggest it must have been introduced by human activity. They also lend new urgency to public health efforts; the South Asian strain is both more virulent and more resistant to antibiotic drugs than those currently circulating in Latin America. Since the outbreak began in October, 93,000 people have become sick and more than 2,000 have died.
Eric Schadt and collaborators at Pacific Biosciences, a sequencing company that has developed a novel method for rapidly reading single molecules of DNA, sequenced and analyzed the microbes’ DNA in just two days. The ability to quickly analyze pathogens is essential if it is to aid public health responses.
According to a release from Pacific Biosciences, which raised $200 million in an initial public offering last month, researchers sequenced five different cholera strains sent from Harvard Medical School: two samples from the current Haiti outbreak, two samples from South Asia (Bangladeshi isolates from 1971 and 2008), and one sample from Latin America (a 1991 Peruvian isolate). The team then compared this high resolution whole genome sequence information to DNA sequence information available in public databases for 23 diverse strains of V. cholerae. The research was published online this week in the New England Journal of Medicine.
According to a commentary in the NEJM,
The implications of the appearance of this strain are worrisome: as compared with many cholera strains, it is associated with increased virulence, enhanced ability to survive in the environment and in a human host, and increased antibiotic resistance. These factors have substantial epidemiologic ramifications for the entire region and implications for optimal public health approaches to arresting the epidemic’s spread.
Keep Reading
Most Popular

Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.

These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.

Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.

A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
Stay connected

Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.